Different Impact of Pretransplant Anti-HLA Antibodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients

Table 2

Univariable study of risk factors of acute rejection in HS group.

	Acute rejection	Non rejection	𝑃
	(𝑛=13)	(𝑛=10)
Age of donor (years, mean ± SD)	40 ± 9	42 ± 5	0.5
Age of recipient (years, mean ± SD)	44 ± 10	43 ± 13	0.8
Number of transplant (0/1/2/3)	0/9/3/1	1/8/1/0	0.4
HLA mismatch (median, IQR)	4 (4-5)	4 (4-5)	0.7
DCD* (%)	54%	50%	0.6
Cold ischemia time (hours, mean ± SD)	18 ± 6	19 ± 7	0.7
Maximum PRA	83 ± 19	65 ± 25	0.07
Current PRA	46 ± 35	25 ± 24	0.2
PRA class I	69 ± 24	81 ± 14	0.3
PRA class II	44 ± 33	28 ± 33	0.3
Pre-transplant DSA (%)	10 (77%)	3 (30%)	0.03
MFI** of DSA (mean ± SD)	6188 ± 1670	5824 ± 2533	0.8

∗DCD: donation after cardiac death.
∗∗MFI: mean fluorescence intensity.